Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine

INTRODUCTION: Currently, there are no FDA-approved medications to treat methamphetamine addiction, including the inflammatory, neurotoxic, and adverse neuropsychiatric effects. We have shown that partial (p)MHC class II constructs (i.e., Recombinant T-cell receptor Ligand – RTL1000), comprised of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Loftis, Jennifer M., Ramani, Sankrith, Firsick, Evan J., Hudson, Rebekah, Le-Cook, Anh, Murnane, Kevin S., Vandenbark, Arthur, Shirley, Renee L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666795/
https://www.ncbi.nlm.nih.gov/pubmed/38025429
http://dx.doi.org/10.3389/fpsyt.2023.1259041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666795/
https://www.ncbi.nlm.nih.gov/pubmed/38025429
http://dx.doi.org/10.3389/fpsyt.2023.1259041

Ejemplares similares